US Stock MarketDetailed Quotes

Nektar Therapeutics (NKTR)

Watchlist
  • 91.680
  • +0.420+0.46%
Close Apr 24 16:00 ET
  • 91.600
  • -0.080-0.09%
Post 20:01 ET
3.04BMarket Cap-9.42P/E (TTM)

Nektar Therapeutics (NKTR) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-18.67%-208.51M
-40.64%-64.96M
-10.99%-48.76M
-21.31%-45.74M
-2.43%-49.05M
8.77%-175.71M
1.83%-46.19M
-4.30%-43.93M
26.82%-37.7M
7.76%-47.89M
Net income from continuing operations
-37.92%-164.08M
-596.89%-36.08M
4.14%-35.52M
20.57%-41.59M
-38.26%-50.88M
56.91%-118.96M
117.26%7.26M
19.15%-37.06M
-2.43%-52.36M
73.14%-36.8M
Operating gains losses
121.61%8.73M
--1.35M
--534K
--2.39M
--4.46M
-731.19%-40.39M
----
----
----
----
Depreciation and amortization
-76.63%1.03M
-42.77%190K
-80.26%196K
-85.33%214K
-73.49%426K
-43.81%4.39M
-79.90%332K
-41.42%993K
-32.64%1.46M
-30.19%1.61M
Deferred tax
----
----
----
----
----
----
----
-106.67%-31K
311.11%57K
97.90%-38K
Other non cash items
20.49%-28.75M
-97.83%-12.04M
43.95%-5.44M
39.10%-4.46M
47.78%-6.81M
17.05%-36.16M
45.64%-6.09M
20.77%-9.71M
-11.72%-7.32M
4.01%-13.04M
Change In working capital
-493.30%-37.02M
-101.03%-23.12M
-1,056.26%-10.17M
-132.97%-3.58M
97.81%-146K
68.71%-6.24M
-136.10%-11.5M
132.87%1.06M
216.03%10.86M
-169.16%-6.66M
-Change in receivables
--0
--0
--0
--0
--0
-163.76%-3.05M
-320.62%-2.2M
2.19%-850K
45.84%2.42M
-180.78%-2.41M
-Change in inventory
--0
--0
--0
--0
--0
-28.90%497K
21.85%1.31M
-94.80%123K
128.12%212K
42.42%-1.14M
-Change in payables and accrued expense
-147.83%-6.41M
-159.80%-7.52M
-165.06%-5.72M
-111.98%-799K
818.67%7.63M
166.51%13.4M
12.41%-2.89M
713.32%8.79M
162.67%6.67M
111.40%830K
-Change in other current assets
-268.98%-15.45M
-306.35%-9.86M
82.73%-618K
-64.73%985K
-510.45%-5.96M
-216.86%-4.19M
-179.82%-2.43M
-3.65%-3.58M
20.86%2.79M
-117.46%-976K
-Change in other working capital
-17.45%-15.16M
-8.80%-5.75M
-11.77%-3.83M
-204.28%-3.77M
38.71%-1.81M
-45.82%-12.91M
-90.66%-5.29M
-45.02%-3.42M
35.89%-1.24M
-65.62%-2.96M
Cash from discontinued investing activities
Operating cash flow
-18.67%-208.51M
-40.64%-64.96M
-10.99%-48.76M
-21.31%-45.74M
-2.43%-49.05M
8.77%-175.71M
1.83%-46.19M
-4.30%-43.93M
26.82%-37.7M
7.76%-47.89M
Investing cash flow
Cash flow from continuing investing activities
-100.84%-1.2M
-99.38%372K
-305.73%-94.87M
192.16%49.62M
126.86%43.69M
2.15%142.57M
246.40%60.21M
-18.25%46.12M
-32.53%16.98M
-52.56%19.26M
Net PPE purchase and sale
88.35%-171K
96.08%-18K
82.88%-114K
80.11%-37K
98.73%-2K
-486.32%-1.47M
-93.67%-459K
-154.95%-666K
-14.81%-186K
63.74%-157K
Net business purchase and sale
-101.07%-697K
----
----
----
----
--65.39M
----
----
----
----
Net investment purchase and sale
-100.42%-329K
108.27%390K
-302.55%-94.76M
189.21%49.65M
128.63%44.39M
-43.49%78.65M
-126.75%-4.71M
-15.25%46.78M
-32.23%17.17M
-52.68%19.42M
Net other investing changes
----
----
--0
--0
---697K
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-100.84%-1.2M
-99.38%372K
-305.73%-94.87M
192.16%49.62M
126.86%43.69M
2.15%142.57M
246.40%60.21M
-18.25%46.12M
-32.53%16.98M
-52.56%19.26M
Financing cash flow
Cash flow from continuing financing activities
328.71%180.57M
46,491.57%38.67M
1,089,723.08%141.68M
1,010.53%211K
-99.98%7K
140,293.33%42.12M
591.67%83K
13K
5.56%19K
42M
Net common stock issuance
6,128.33%180.85M
--38.26M
--142.59M
--0
--0
---3M
--0
--0
--0
---3M
Proceeds from stock option exercised by employees
-97.12%866K
393.98%410K
1,730.77%238K
1,010.53%211K
-99.98%7K
100,293.33%30.12M
591.67%83K
--13K
5.56%19K
--30M
Net other financing activities
-107.67%-1.15M
--0
----
----
----
--15M
--0
--0
--0
--15M
Cash from discontinued financing activities
Financing cash flow
328.71%180.57M
46,491.57%38.67M
1,089,723.08%141.68M
1,010.53%211K
-99.98%7K
140,293.33%42.12M
591.67%83K
--13K
5.56%19K
--42M
Net cash flow
Beginning cash position
25.44%44.25M
36.28%41.03M
53.86%42.99M
-20.04%38.89M
25.44%44.25M
-60.02%35.28M
-53.62%30.11M
-44.92%27.94M
-36.79%48.64M
-60.02%35.28M
Current changes in cash
-424.56%-29.14M
-283.67%-25.92M
-189.08%-1.96M
119.75%4.09M
-140.06%-5.36M
116.94%8.98M
147.59%14.11M
-84.63%2.2M
21.39%-20.7M
218.17%13.37M
Effect of exchange rate changes
250.00%6K
--0
103.57%1K
700.00%6K
87.50%-1K
-106.45%-4K
312.50%33K
71.43%-28K
-100.93%-1K
-117.78%-8K
End cash Position
-65.84%15.12M
-65.84%15.12M
36.28%41.03M
53.86%42.99M
-20.04%38.89M
25.44%44.25M
25.44%44.25M
-53.62%30.11M
-44.92%27.94M
-36.79%48.64M
Free cash flow
-17.78%-208.68M
-39.30%-64.98M
-9.59%-48.88M
-20.82%-45.78M
-2.10%-49.06M
8.42%-177.18M
1.35%-46.65M
-5.80%-44.6M
26.69%-37.89M
8.22%-48.05M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -18.67%-208.51M-40.64%-64.96M-10.99%-48.76M-21.31%-45.74M-2.43%-49.05M8.77%-175.71M1.83%-46.19M-4.30%-43.93M26.82%-37.7M7.76%-47.89M
Net income from continuing operations -37.92%-164.08M-596.89%-36.08M4.14%-35.52M20.57%-41.59M-38.26%-50.88M56.91%-118.96M117.26%7.26M19.15%-37.06M-2.43%-52.36M73.14%-36.8M
Operating gains losses 121.61%8.73M--1.35M--534K--2.39M--4.46M-731.19%-40.39M----------------
Depreciation and amortization -76.63%1.03M-42.77%190K-80.26%196K-85.33%214K-73.49%426K-43.81%4.39M-79.90%332K-41.42%993K-32.64%1.46M-30.19%1.61M
Deferred tax -----------------------------106.67%-31K311.11%57K97.90%-38K
Other non cash items 20.49%-28.75M-97.83%-12.04M43.95%-5.44M39.10%-4.46M47.78%-6.81M17.05%-36.16M45.64%-6.09M20.77%-9.71M-11.72%-7.32M4.01%-13.04M
Change In working capital -493.30%-37.02M-101.03%-23.12M-1,056.26%-10.17M-132.97%-3.58M97.81%-146K68.71%-6.24M-136.10%-11.5M132.87%1.06M216.03%10.86M-169.16%-6.66M
-Change in receivables --0--0--0--0--0-163.76%-3.05M-320.62%-2.2M2.19%-850K45.84%2.42M-180.78%-2.41M
-Change in inventory --0--0--0--0--0-28.90%497K21.85%1.31M-94.80%123K128.12%212K42.42%-1.14M
-Change in payables and accrued expense -147.83%-6.41M-159.80%-7.52M-165.06%-5.72M-111.98%-799K818.67%7.63M166.51%13.4M12.41%-2.89M713.32%8.79M162.67%6.67M111.40%830K
-Change in other current assets -268.98%-15.45M-306.35%-9.86M82.73%-618K-64.73%985K-510.45%-5.96M-216.86%-4.19M-179.82%-2.43M-3.65%-3.58M20.86%2.79M-117.46%-976K
-Change in other working capital -17.45%-15.16M-8.80%-5.75M-11.77%-3.83M-204.28%-3.77M38.71%-1.81M-45.82%-12.91M-90.66%-5.29M-45.02%-3.42M35.89%-1.24M-65.62%-2.96M
Cash from discontinued investing activities
Operating cash flow -18.67%-208.51M-40.64%-64.96M-10.99%-48.76M-21.31%-45.74M-2.43%-49.05M8.77%-175.71M1.83%-46.19M-4.30%-43.93M26.82%-37.7M7.76%-47.89M
Investing cash flow
Cash flow from continuing investing activities -100.84%-1.2M-99.38%372K-305.73%-94.87M192.16%49.62M126.86%43.69M2.15%142.57M246.40%60.21M-18.25%46.12M-32.53%16.98M-52.56%19.26M
Net PPE purchase and sale 88.35%-171K96.08%-18K82.88%-114K80.11%-37K98.73%-2K-486.32%-1.47M-93.67%-459K-154.95%-666K-14.81%-186K63.74%-157K
Net business purchase and sale -101.07%-697K------------------65.39M----------------
Net investment purchase and sale -100.42%-329K108.27%390K-302.55%-94.76M189.21%49.65M128.63%44.39M-43.49%78.65M-126.75%-4.71M-15.25%46.78M-32.23%17.17M-52.68%19.42M
Net other investing changes ----------0--0---697K--------------------
Cash from discontinued investing activities
Investing cash flow -100.84%-1.2M-99.38%372K-305.73%-94.87M192.16%49.62M126.86%43.69M2.15%142.57M246.40%60.21M-18.25%46.12M-32.53%16.98M-52.56%19.26M
Financing cash flow
Cash flow from continuing financing activities 328.71%180.57M46,491.57%38.67M1,089,723.08%141.68M1,010.53%211K-99.98%7K140,293.33%42.12M591.67%83K13K5.56%19K42M
Net common stock issuance 6,128.33%180.85M--38.26M--142.59M--0--0---3M--0--0--0---3M
Proceeds from stock option exercised by employees -97.12%866K393.98%410K1,730.77%238K1,010.53%211K-99.98%7K100,293.33%30.12M591.67%83K--13K5.56%19K--30M
Net other financing activities -107.67%-1.15M--0--------------15M--0--0--0--15M
Cash from discontinued financing activities
Financing cash flow 328.71%180.57M46,491.57%38.67M1,089,723.08%141.68M1,010.53%211K-99.98%7K140,293.33%42.12M591.67%83K--13K5.56%19K--42M
Net cash flow
Beginning cash position 25.44%44.25M36.28%41.03M53.86%42.99M-20.04%38.89M25.44%44.25M-60.02%35.28M-53.62%30.11M-44.92%27.94M-36.79%48.64M-60.02%35.28M
Current changes in cash -424.56%-29.14M-283.67%-25.92M-189.08%-1.96M119.75%4.09M-140.06%-5.36M116.94%8.98M147.59%14.11M-84.63%2.2M21.39%-20.7M218.17%13.37M
Effect of exchange rate changes 250.00%6K--0103.57%1K700.00%6K87.50%-1K-106.45%-4K312.50%33K71.43%-28K-100.93%-1K-117.78%-8K
End cash Position -65.84%15.12M-65.84%15.12M36.28%41.03M53.86%42.99M-20.04%38.89M25.44%44.25M25.44%44.25M-53.62%30.11M-44.92%27.94M-36.79%48.64M
Free cash flow -17.78%-208.68M-39.30%-64.98M-9.59%-48.88M-20.82%-45.78M-2.10%-49.06M8.42%-177.18M1.35%-46.65M-5.80%-44.6M26.69%-37.89M8.22%-48.05M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More